Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ferric carboxymaltose for treatment of iron deficiency anemia in patients listed for liver transplantation
2017-000703-24Phase 4Terminated
- Sponsor
- Medical University of Vienna
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Medical University of Vienna. Primary endpoint: Change in hemoglobin concentration. Started Oct 2017; status: terminated.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2017-000703-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000703-24.